SueWallSt reminds Insulet Corporation investors that the lead plaintiff deadline for a pending securities class action is August 31, 2026. The lawsuit covers shareholders who purchased Insulet securities between February 21, 2025 and May 26, 2026, alleging the company made misleading statements about its manufacturing quality and product safety. Insulet's stock fell from approximately $236 to $146.01 after two Medical Device Corrections disclosed in March and May 2026, with the second affecting roughly 7 million Omnipod Pods across multiple product lines. The complaint also alleges that insiders sold $5.9 million in stock during the class period. Investors may contact SueWallSt, powered by Levi & Korsinsky LLP, for a no-cost case evaluation.
Insulet CorporationSecurities class action alleging misleading statements about manufacturing quality and product safety, with stock drop and insider sales.